« Previous
Next »
British Journal of Oral and Maxillofacial Surgery
Volume 48, Issue 1
, Pages 30-36
, January 2010
Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma
References
- . Notch signaling. Clin Cancer Res. 2006;12:1074–1079
- . Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006;107:2223–2233
- . Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 2002;16:2252–2263
- . T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol. 2004;11:426–433
- . Notch signaling and cancer: emerging complexity. Semin Cancer Biol. 2004;14:317–319
- . The role of Notch in tumorigenesis: oncogene or tumor suppressor?. Nat Rev Cancer. 2003;3:756–767
- . Notch and cancer: best to avoid the ups and downs. Cancer Cell. 2003;3:203–205
- . Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev. 2004;14:48–54
- . The Notch pathway in cancer: differentiation gone awry. Eur J Cancer. 2005;41:2620–2629
- . Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk. Crit Rev Biochem Mol Biol. 2006;41:339–385
- . Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin Cancer Biol. 2004;14:374–386
- . Sequential signaling through Notch1 and erbB receptors mediates radial glia differentiation. J Neurosci. 2003;23:6132–6140
- . The love-hate relationship between Ras and Notch. Genes Dev. 2005;19:1825–1839
- EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol. 2008;10:902–911
- Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2–16
- . The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol. 2006;(May):1–11
- . Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res. 2006;12:87–91
- High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007;43:193–198
- . Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol. 2006;24:2666–2672
- . Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol. 2006;57:25–43
- . Nitric oxide induces oral squamous cell carcinoma cells apoptosis with p53 accumulation. Oral Oncol. 2005;41:785–790
- Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001;61:3200–3205
- Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res. 2003;63:8323–8329
- . Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells. Biol Cell. 2006;98:479–490
- Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev. 2007;21:562–577
PII: S0266-4356(09)00090-4
doi: 10.1016/j.bjoms.2009.03.008
© 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
British Journal of Oral and Maxillofacial Surgery
Volume 48, Issue 1
, Pages 30-36
, January 2010
